title: Defining success in treating patients with inflammatory bowel disease.
authors.affiliation: a Gastrounit, Medical Division , Copenhagen University Hospital Hvidovre , Hvidovre , Denmark.
authors.forename: K
authors.initials: K
authors.lastname: Theede
authors.affiliation: b Department of gastroenterology , North Zealand University Hospital , Frederikssund , Denmark.
authors.forename: J
authors.identifier: 0000-0002-3312-5139
authors.initials: J
authors.lastname: Burisch
mesh_terms: D000893:Anti-Inflammatory Agents; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D039841:Leukocyte L1 Antigen Complex / Q000378:metabolism; D058990:Molecular Targeted Therapy; D017060:Patient Satisfaction; D010817:Physician-Patient Relations; D011788:Quality of Life; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000378:metabolism*
chemical_list: D000893:Anti-Inflammatory Agents; D039841:Leukocyte L1 Antigen Complex; D014409:Tumor Necrosis Factor-alpha
keywords: Crohn’s disease; disability; mucosal healing; treatment; ulcerative colitis